glp-1 brands list glp 1 receptor agonists brand names Understanding Agonists: Key Insights for Payers glp-1 receptor agonist brand names

As more evidence emerges on their utilization, expect this to continue to grow

Strengths Multiple active compounds with complementary effects Good human evidence for glycemic benefit Relatively well tolerated Limitations Some GI discomfort or bloating Varying potency in commercial preparations American Ginseng Best for: Someone already using glucose-lowering therapy who wants a botanical adjunct, or someone wanting broader metabolic support (insulin, lipid, and inflammation modulation)

Indications: Type 2 Diabetes Mellitus (monotherapy or add-on therapy) Especially useful in patients who cannot tolerate metformin or sulfonylureas Can be used in elderly and patients with mild renal impairment Approved Agents in India: Sitagliptin (Januvia) Vildagliptin (Galvus) Saxagliptin (Onglyza) Linagliptin (Trajenta) No renal dose adjustment needed Alogliptin (Nesina) Dosing: Once daily oral dosing Some agents require renal dose adjustment (except Linagliptin) Often combined with metformin or SGLT2 inhibitors Side Effects: Nasopharyngitis, headache GI upset (mild) Rare: Acute pancreatitis, severe joint pain, skin reactions Saxagliptin may slightly increase risk of heart failure in some patients Advantages Over Other Classes: Weight neutral Low risk of hypoglycemia Well tolerated in the elderly Convenient once-daily dosing Limitations: Modest HbA1c reduction (0.50.8%) Not effective in Type 1 Diabetes Less potent than GLP-1 analogs or SGLT2 inhibitors Conclusion: DPP-4 inhibitors are a safe, effective, and well-tolerated option for many patients with T2DM especially those needing an add-on to metformin or who can't tolerate injectables

Menopause triggers metabolic shifts that make weight management harder for many women